UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials

BMC cancer, 2010-06, Vol.10 (1), p.337-337, Article 337

2010

Volltextzugriff (PDF)

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

The lancet oncology, 2017-07, Vol.18 (7), p.929-945

2017

Volltextzugriff (PDF)

Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage

Health and quality of life outcomes, 2020-11, Vol.18 (1), p.353-12, Article 353

2020

Volltextzugriff (PDF)

Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT)

BMJ open, 2022-12, Vol.12 (12), p.e066252

2022

Volltextzugriff (PDF)

Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide

European journal of cancer (1990), 2017-01, Vol.71, p.15-24

2017

Volltextzugriff (PDF)

Rare, germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis

Journal of clinical oncology, 2013-06, Vol.31 (16), p.e245-e247

2013

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules

Clinical cancer research, 2005-11, Vol.11 (21), p.7834-7840

2005

Volltextzugriff (PDF)

Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer

Journal of clinical oncology, 2009-02, Vol.27 (4), p.526-534

2009

Volltextzugriff (PDF)

Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy

Pharmacogenetics and genomics, 2011-12, Vol.21 (12), p.808-819

2011

Volltextzugriff (PDF)

Metastatic disease of the breast and local recurrence

Surgery (Oxford), 2019-03, Vol.37 (3), p.181-185

Verrill, Mark

2019

Volltextzugriff (PDF)

Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma

Journal of immunological methods, 2009-06, Vol.345 (1), p.106-111

2009

Volltextzugriff (PDF)

Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2002-08, Vol.20 (16), p.3533-3544

2002

Volltextzugriff (PDF)

The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib

Cancer chemotherapy and pharmacology, 2011-12, Vol.68 (6), p.1485-1495

2011

Volltextzugriff (PDF)

An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer

Health and quality of life outcomes, 2005-07, Vol.3 (1), p.41-41, Article 41

2005

Volltextzugriff (PDF)

Metastatic disease of the breast and local recurrence

Surgery (Oxford), 2016, Vol.34 (1), p.47-51

Verrill, Mark

2016

Volltextzugriff (PDF)

A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer

Clinical cancer research, 2007-06, Vol.13 (12), p.3652-3659

2007

Volltextzugriff (PDF)

Capecitabine and vinorelbine in metastatic breast cancer

European journal of cancer (1990), 2009-09, Vol.45 (13), p.2253-2265

2009

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies

Clinical cancer research, 2008-12, Vol.14 (24), p.8288-8294

2008

Volltextzugriff (PDF)

The rise of oncology biosimilars: from process to promise

Future oncology (London, England), 2019-10, Vol.15 (28), p.3255-3265

2019

Volltextzugriff (PDF)

A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer

British journal of cancer, 2024-04, Vol.130 (7), p.1149-1156

2024

Volltextzugriff (PDF)

A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program

British journal of cancer, 2023-09, Vol.129 (5), p.852-860

2023

Volltextzugriff (PDF)

P086. Pathological response in the breast following dual anti-HER2 neoadjuvant chemotherapy for breast cancer

European journal of surgical oncology, 2019-05, Vol.45 (5), p.908-908

2019

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(93)

Sprache

Englisch
(92)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(56)
Humans
(51)
Female
(37)
Oncology
(36)
Breast Cancer
(23)
Middle Aged
(23)
Adult
(22)
Male
(22)
Breast Neoplasms - Drug Therapy
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Chemotherapy
(15)
Aged
(14)
Tumors
(13)
Patients
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Cancer Therapies
(10)
Pharmacology. Drug Treatments
(10)
Breast Neoplasms - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage

Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study

Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT)

Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide

Rare, germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis

A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules

Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer

Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy

Metastatic disease of the breast and local recurrence

Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma

Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma

The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib

An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer

Metastatic disease of the breast and local recurrence

A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer

Capecitabine and vinorelbine in metastatic breast cancer

A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies

The rise of oncology biosimilars: from process to promise

A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer

A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program

P086. Pathological response in the breast following dual anti-HER2 neoadjuvant chemotherapy for breast cancer

Suchergebnisse filtern